Voltammetric determination of cefotaxime using potassium peroxomonosulfate
Keywords:voltammetry, cefotaxime, potassium peroxomonosulfate
AbstractThe presented article is dedicated to the development of new procedure for quantitative voltammetric determination of cefotaxime powder for injection solution preparation in the form of corresponding S-oxide in weak acidic medium using potassium hydrogenperoxomonosulfate (KHSO5) as an analytical reagent. Voltammogramms of cefotaxime S-oxide solutions for different concentrations of cephalosporins were scanned. There are two peaks on the voltammetric curve of the cefotaxime S-oxide solution: at -0.65 V (that corresponds to potassium peroxomonosulfate) and -1.3 V (peak height was rising proportionally to cefotaxime concentrations increasing) that has been chosen as analytical. The calibration curve method can be easily applied. Linearity has been studied over a drug concentration range from 1·10-4 to 1·10-3 mol L-1. The correlation coefficient r=0.999. Precision and accuracy have been studied by analyzing five replicates of the sample solutions at three concentrations levels. The calculated relative standard deviations were below 1.75 %, d ≤ -1.1 % indicating excellent precision of the proposed procedure. The Limit of Detection (LOD) and the Limit of Quantification (LOQ) were calculated (LOD=1.2·10-5 mol L-1 and LOQ= 4·10-5 mol L-1). The proposed voltammetric method is sensitive enough, accurate, precise, replicable and linear to enable determination of lower amounts of drug. These advantages encourage the application of the method in routine quality control of cefotaxime in industrial laboratories.
Al-Momani I. F. // J. Pharm. Biomed. Anal. – 2001. – V. 25. – P. 751-757.
Basaez L., Vanysek P. // Journal of Pharmaceutical and Biomedical Analysis. – 1999. – V.19. – P.183-192.
Fogg A.G., Fayad N.M., Burgess C. // Anal. Chim. Acta. – 1979. – V. 110. – P. 107-115.
Fogg A.G., Fayad N.M., Burgess C., McGlynn A. // Analyt. Chim. Acta. –1979. – V. 108. – P. 205-211.
Mrestani Ya., Neubert R.H. H., Härtl A. // Analytica Chimica Acta. – 1997. – V. 49. – P. 207-213
Nuñez-Vergara L. J., Squella J.A., Silva M.M. // Talanta. – 1982. – V.29. – P. 137-138.
Ogoverk B., Hudnik V., Gomiscek S. // Frensenius Z. Anal. Chem. – 1988. – V.330. – Р.59-64.
Ogoverk B., Gomiscek S. // J. Pharm. and Biomed. Anal. – 1991. – V.9. – Р.225-236.
Omar M., Adbelmageed O., Attia T. // Talanta. – 2009. – V. 77. – P. 1394-1404.
Saleh A., Askal H. //Talanta. – 2001. – V. 54. – P. 1205-1215.
Samanidou F., Ioannou A. S., Papadoyannis I. N. // J. Chromat. B. – 2003. – V. 788. – 147-158.
Samanidou V. F., Hapeshi E. A., Papadoyannis I. N. //J. Chromat. B. – 2004. – V. 809. – P. 175-182.
Zuman P., Kapetanovic V., Aleksic M. // Anal. Lett. – 2000. – V.33. – P. 2821-2857
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).